Status | Study |
Not yet recruiting |
Study Name: Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy Condition: Chromosome Abnormality Twin Pregnancy With Antenatal Problem Date: 2016-11-29 Interventions: Procedure: Fetal Selective Reduction Technology |
Enrolling by invitation |
Study Name: Utilizing Free DNA in Embryo Culture for PGS Condition: Chromosome Abnormalities Genetic Diseases, Inborn Date: 2016-08-22 Interventions: Procedure: NGS reading for Media Free DNA NGS reading for Media Free DNA instead of blstomer biopsy |
Not yet recruiting |
Study Name: The Value of Prenatal Ultrasound in Complicated Twin Pregnancy and Its Correlation With Chromosomal Anomalies Condition: Complicated Twin Pregnancy Date: 2016-03-16 Interventions: Other: ultrasound (observation) Important sonographic indi |
Not yet recruiting |
Study Name: Electronic Nose and Fetal Chromosomal Disorders Condition: Detecting Abnormal Fetal Karyotype by the Electronic Nose Date: 2015-09-03 Interventions: Other: observational study done only in women candidate for amniocentesis As a part of routine test in w |
Completed |
Study Name: Study on the Impact of Stem Cell Donation and Bone Marrow Harvesting on Unrelated Donors Condition: Chromosome Aberrations Date: 2013-06-18 |
Completed |
Study Name: Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test) Condition: Non-small Cell Lung Cancer (NSCLC) Date: 2012-06-13 |
Terminated |
Study Name: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler Condition: Acute Myeloid Leukemia (AML) Acute Promyelocytic Leukemia (APL) Date: 2011-10-28 |
Completed |
Study Name: Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test Condition: Post-natal Cytogenetics Date: 2011-08-29 |
Completed |
Study Name: Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test) Condition: Bladder Cancers Date: 2010-12-21 |
Completed |
Study Name: Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities Condition: Myelodysplastic Syndromes Leukemia, Myeloid, Acute Date: 2009-06-05 Interventions: Drug: 5 azacytidine Patients will receive azacytidine 75 mg/m2/day SC for 7 days every 28 days for up to |